Indegene is currently trading at Rs. 603.75, up by 2.50 points or 0.42% from its previous closing of Rs. 601.25 on the BSE.
The scrip opened at Rs. 606.95 and has touched a high and low of Rs. 607.20 and Rs. 594.00 respectively. So far 498416 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 627.00 on 29-Sep-2026 and a 52 week low of Rs. 414.90 on 23-Mar-2026.
Last one week high and low of the scrip stood at Rs. 607.20 and Rs. 564.05 respectively. The current market cap of the company is Rs. 14574.64 crore.
The institutions and non-institutions held 28.22% and 71.77% stake in the company respectively.
Indegene has incorporated a step-down wholly owned subsidiary (WOS) by name Indegene Portugal, Unipessoal LDA, on October 23, 2026. Indegene Ireland, a wholly owned subsidiary of the company, holds 100% of the share capital of Indegene Portugal, Unipessoal LDA.
The step-down subsidiary will provide services for the life sciences, healthcare, and biopharmaceutical sectors; Corporate services for other affiliated entities; Content development and technology support services; Support services related to clinical development and medical affairs; Support services related to medical education and communications.
Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products.
